A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

The innovation-focused investment firm has long held shares in Intellia, likely because of its work on potentially disruptive ...

Groups of districts already working on escaping the factory model applied for grant money to work on innovative high school options.

According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...